Emerging Trends Shaping the Asthma and COPD Drugs Market
The Asthma and COPD Drugs Market was estimated at US$ 37.9 billion in 2021 and is expected to grow at a CAGR of 5.34% during 2022-2028 to reach US$ ~54.40 billion in 2028.
North America dominates the asthma and COPD drugs market due to increasing incidences of asthma, with approximately 25 million Americans predicted to have asthma by 2020.